Aayoung Hong

2.8k citations

11 papers · 1.8k indexed · 2 hit papers · h-index 9

Molecular Biology top 5%
Oncology top 2%
Immunology top 10%
Computational Theory and Mathematics top 2%
Cancer Research top 10%

Co-authors: Roger S. Lo Gatien Moriceau Willy Hugo Antoni Ribas Xiangju Kong Hubing Shi Douglas B. Johnson Jeffrey A. Sosman
Topics: Melanoma and MAPK Pathways (9 papers)Cutaneous Melanoma Detection and Management (4 papers)Protein Kinase Regulation and GTPase Signaling (3 papers)
Cited by: Oncology Molecular Biology Computational Theory and Mathematics
Journals: Cell Cancer Cell International Journal of Radiation Oncology*Biology*Physics
Partner nations: United States Australia Belgium

In The Last Decade

Aayoung Hong

10 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy

2013 715 citations Hubing Shi, Willy Hugo et al. Cancer Discovery profile →
Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance

2015 412 citations Willy Hugo, Hubing Shi et al. Cell profile →

Peers

Countries citing papers authored by Aayoung Hong

Since Specialization

Citations

This map shows the geographic impact of Aayoung Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aayoung Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aayoung Hong more than expected).

Fields of papers citing papers by Aayoung Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aayoung Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aayoung Hong. The network helps show where Aayoung Hong may publish in the future.

Co-authorship network of co-authors of Aayoung Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Aayoung Hong. A scholar is included among the top collaborators of Aayoung Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aayoung Hong. Aayoung Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma 2023 ·Cancer Discovery ·(unknown),Xiao Zhang,Sixue Liu,Shirley H. Lomeli,Aayoung Hong,(unknown),Zhentao Yang,(unknown),Agustin Vega-Crespo,Antoni Ribas,Stergios J. Moschos,Gatien Moriceau,Roger S. Lo	53
2	Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma 2021 ·Cell Reports Medicine ·Sixue Liu,Hannah M. Knochelmann,Shirley H. Lomeli,Aayoung Hong,Mary S. Richardson,Zhentao Yang,Raymond J. Lim,Yan Wang,Camelia Dumitras,Kostyantyn Krysan,Cynthia Timmers,Martin J. Romeo,Carsten Krieg,Elizabeth C. O’Quinn,Joshua D. Horton,(unknown),Chrystal M. Paulos,David M. Neskey,Roger S. Lo	31
3	Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma 2020 ·UNC Libraries ·Willy Hugo,Gatien Moriceau,Robert Damoiseaux,Roger S. Lo,(unknown),Aayoung Hong,Sheri L. Holmen,Shirley H. Lomeli,Norman E. Sharpless,Marco Piva	0
4	Recurrent Tumor Cell–Intrinsic and –Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation 2017 ·Cancer Discovery ·Chunying Song,Marco Piva,Lu Sun,Aayoung Hong,Gatien Moriceau,Xiangju Kong,Hong Zhang,Shirley H. Lomeli,Jin Qian,Clarissa C. Yu,Robert Damoiseaux,Mark C. Kelley,(unknown),Philip O. Scumpia,Jeffrey A. Sosman,Douglas B. Johnson,Antoni Ribas,Willy Hugo,Roger S. Lo	109
5	Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma 2017 ·Cancer Discovery ·Aayoung Hong,Gatien Moriceau,Lu Sun,Shirley H. Lomeli,Marco Piva,Robert Damoiseaux,Sheri L. Holmen,Norman E. Sharpless,Willy Hugo,Roger S. Lo	72
6	JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma 2016 ·Cell Discovery ·Bjoern Titz,Anastasia Lomova,(unknown),Willy Hugo,Xiangju Kong,Johanna ten Hoeve,Michael Friedman,Hubing Shi,Gatien Moriceau,Chunying Song,Aayoung Hong,Mohammad Atefi,Richard Li,Evangelia Komisopoulou,Antoni Ribas,Roger S. Lo,Thomas G. Graeber	43
7	Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction 2015 ·Cancer Cell ·Gatien Moriceau,Willy Hugo,Aayoung Hong,Hubing Shi,Xiangju Kong,Clarissa C. Yu,Richard C. Koya,Ahmed A. Samatar,Négar Khanlou,Jonathan Braun,Kathleen Ruchalski,Heike Seifert,James Larkin,Kimberly B. Dahlman,Douglas B. Johnson,Alain P. Algazi,Jeffrey A. Sosman,Antoni Ribas,Roger S. Lo	237
8	Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistancebreakdown → 2015 ·Cell ·Willy Hugo,Hubing Shi,Lu Sun,Marco Piva,Chunying Song,Xiangju Kong,Gatien Moriceau,Aayoung Hong,Kimberly B. Dahlman,Douglas B. Johnson,Jeffrey A. Sosman,Antoni Ribas,Roger S. Lo	412
9	Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapybreakdown → 2013 ·Cancer Discovery ·Hubing Shi,Willy Hugo,Xiangju Kong,Aayoung Hong,Richard C. Koya,Gatien Moriceau,Thinle Chodon,Rongqing Guo,Douglas B. Johnson,Kimberly B. Dahlman,Mark C. Kelley,Richard Kefford,Bartosz Chmielowski,John A. Glaspy,Jeffrey A. Sosman,Nicolas van Baren,Georgina V. Long,Antoni Ribas,Roger S. Lo	715
10	A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition 2013 ·Cancer Discovery ·Hubing Shi,Aayoung Hong,Xiangju Kong,Richard C. Koya,Chunying Song,Gatien Moriceau,Willy Hugo,Clarissa C. Yu,Charles Ng,Thinle Chodon,Richard A. Scolyer,Richard Kefford,Antoni Ribas,Georgina V. Long,Roger S. Lo	133
11	Adjuvant Radiotherapy Improves Regional (Lymph Node Field) Control in Melanoma Patients after Lymphadenectomy 2009 ·International Journal of Radiation OncologyBiologyPhysics ·B. Burmeister,M. Henderson,John F. Thompson,R I Fisher,Juliana Di Iulio,B. Mark Smithers,Aayoung Hong,Scott Carruthers,Harald Hoekstra,Jill Ainslie	1

About Aayoung Hong

Aayoung Hong is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 11 papers that have together received 1.8k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (9 papers), Cutaneous Melanoma Detection and Management (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). The work is most often cited by research in Oncology (1.0k citations), Molecular Biology (1.5k citations) and Computational Theory and Mathematics (273 citations). Aayoung Hong has collaborated with scholars based in United States, Australia and Belgium. Frequent co-authors include Roger S. Lo, Gatien Moriceau, Willy Hugo, Antoni Ribas, Xiangju Kong, Hubing Shi, Douglas B. Johnson, Jeffrey A. Sosman, Kimberly B. Dahlman and Richard C. Koya. Their work appears in journals such as Cell, Cancer Cell and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact